HSA — authorised 27 January 2023
- Marketing authorisation holder: STEMLINE THERAPEUTICS INC
- Status: likely_approved
🇸🇬 Orserdu in Singapore
HSA authorised Orserdu on 27 January 2023
Marketing authorisation
Orserdu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Orserdu approved in Singapore?
Yes. HSA authorised it on 27 January 2023.
Who is the marketing authorisation holder for Orserdu in Singapore?
STEMLINE THERAPEUTICS INC holds the Singaporean marketing authorisation.